Derrell Porter - SVP, Atara Biotherapeutics, Inc
As of March 27, 2019
Derrell Porter Net Worth
- Net worth is estimated to be at least $1.35M
- Owns at least 21,688 units of Atara Biotherapeutics, Inc stock
- Sold an estimated value of $1.08M in the last 2 years at Atara Biotherapeutics, Inc
Derrell Porter Trading
- Largest purchase of shares was 16,334 units , worth over $233.58K on May 16, 2018
- Largest sale of shares was 16,334 units , worth over $735.36K on May 16, 2018
- In total has made about 7 transactions over 2 years
- Usually trades in February and May, with the busiest year in 2019 and 2018
Derrell Porter
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Derrell Porter Mailing Address
- Mailing address is C/o Atara Biotherapeutics, Inc. 611 Gateway Blvd. #900 South San Francisco CA 94080 CA
Atara Biotherapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Pascal Touchon, D.V.M. | 2020 | $654,857 | $422,500 | $2,235,600 | $1,959,208 | $13,662 | $5,285,827 |
| Pascal Touchon, D.V.M. | 2019 | $319,327 | $334,791 | $2,861,712 | $3,049,718 | $71,760 | $6,637,307 |
| Jakob Dupont, M.D. | 2020 | $319,231 | $143,346 | $443,075 | $1,757,296 | $133,297 | $2,796,245 |
| Utpal Koppikar | 2020 | $460,947 | $187,032 | $885,431 | $597,073 | $7,470 | $2,137,953 |
| Utpal Koppikar | 2019 | $439,875 | $155,606 | $1,034,714 | $909,080 | $895 | $2,540,170 |
| Utpal Koppikar | 2018 | $240,289 | $189,771 | $1,903,500 | $1,886,325 | $398 | $4,220,282 |
| Joseph Newell | 2020 | $466,055 | $203,435 | $1,033,965 | $566,713 | $895 | $2,251,063 |
| Joseph Newell | 2019 | $390,000 | $155,208 | $1,240,675 | $932,390 | $895 | $2,719,167 |
| Joseph Newell | 2018 | $365,000 | $155,490 | $895,000 | $1,060,710 | $16,092 | $2,492,292 |
| Kristin Yarema, Ph.D. | 2020 | $368,308 | $147,995 | $668,250 | $1,067,484 | $184,370 | $2,436,407 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm
Atara Biotherapeutics, Inc Insider Trading
- The most recent transaction was 3,223 units sold on May 19, 2022 by Amar Murugan worth over $17.13K
- In the last 8 years, insiders at Atara Biotherapeutics, Inc sold an estimated value of $72.85M and bought an estimated value of $10.47M
- The most active traders are Isaac E Ciechanover, Chief Executive Officer, Christopher Haqq, EVP, and Joe Newell, Chief Operations Officer
- Insider trading is most common in February, with the busiest year in 2018
Atara Biotherapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||